Elon Musk recently announced that Neuralink is gearing up for large-scale manufacturing of brain-computer interface devices, with a major operational shift planned for 2026. The company is moving toward a fully streamlined and largely automated surgical implantation procedure. This marks a significant step in making the technology more accessible and production-efficient. The shift from manual to automated surgical processes could reduce operational overhead while potentially improving consistency in implantation outcomes. Neuralink's progress in scaling manufacturing represents a pivotal moment for neural interface technology, drawing attention from investors and tech enthusiasts tracking innovations at the intersection of neuroscience and computing.